• Global Medical Occluder Device market size was valued at USD 1.46 billion in 2024. The market is projected to grow from USD 1.64 billion in 2025 to USD 3.28 billion by 2032, exhibiting a CAGR of 12.6% during the forecast period.
Email:
• Medical Occluder Devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These self-expandable, umbrella-like devices are manufactured from biocompatible materials such as nitinol or stainless steel mesh. They are primarily used to treat congenital heart defects including atrial septal defects (ASD), ventricular septal defects (VSD), and patent ductus arteriosus (PDA), offering a minimally invasive alternative to open-heart surgery.
Email: help@intelmarketresearch.com +91 9169164321
By Types
Cardiac Occluders
Vascular Occluders
Other Occluder
By Applications
• Ischemic Stroke Prevention
• Peripheral Arterial Disease • Pulmonary Embolism
• Varicose Veins
• Congenital Heart Defects (ASD, VSD, PDA, PFO)
• Other Indications
Email: help@intelmarketresearch.com +91 9169164321
Key Players :
•Abbott Laboratories (U.S.)
•Boston Scientific Corporation (U.S.)
•LifeTech Scientific Corporation (China)
•Lepu Medical Technology (Beijing) Co., Ltd. (China)
•Occlutech Holding AG (Germany)
•W. L. Gore & Associates (U.S.)
•Starway Medical Technology Inc. (China)
•Coherex Medical (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
